ISPOR - Reimbursement Recommendations for Cancer Products Without Statistically Significant Overall Survival Data- A Review of Canadian Pcodr Decisions

Full Text

Reimbursement Recommendations for Cancer Products Without Statistically Significant Overall Survival Data- A Review of Canadian Pcodr Decisions

Abstract

Authors

K. Heyland I.A. Samjoo D.T. Grima

Back to Volume 17, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now